Roughly 28% of state Medicaid agencies already offer coverage of weight loss drugs, with beneficiaries paying nominal out-of-pocket costs of at most $3 per prescription
Recently, peptides has become a buzzword in the medical and wellness fields, climbing out of the niche circles of biohackers and into the mainstream spotlight on social media
This story mentions GLP-1 drugs, which are FDA-approved for weight management in adults diagnosed with obesity or with overweight and at least one weight-related health condition
Epidemiological evidence shows strong associations between gut microbiota profiles and cardiovascular risk markers, largely mediated through bioactive microbial metabolites that directly influence cardiovascular pathophysiology [30]
Compounded injectable GLP-1s typically come in multi-dose vials requiring the patient to draw and measure their own dose with a syringe
BPC-157 is being studied for its potential anti-inflammatory properties, which may help support comfort and recovery
